MRC1 and neoplasm: TMB, MSI and MMR deficiency influence tumor initiation and were considered an independent predictor of treatment effectiveness with ICB (Sahin et al., 2019; Samstein et al., 2019; Zhao et al., 2019; Sha et al., 2020).